New study uses DNA to track hidden gonorrhea in partners
NCT ID NCT07671014
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study will recruit 100 sexual partners of people diagnosed with gonorrhea. Researchers will take an extra throat swab to analyze all the bacteria and their genes using a technique called metagenomics. The goal is to find hidden infections, antibiotic resistance, and see how prevention strategies like a vaccine and antibiotics might work.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 4CMenB vaccine and doxycycline post-exposure prophylaxis (DoxyPEP)
- What this could lead to
- If successful, this study could help doctors better understand how gonorrhea spreads and how to use vaccines and antibiotics to prevent it.
- What could go wrong
- This is a small, early-stage observational study, so it may not lead to immediate changes in treatment. The DNA testing is for research only and not yet proven to improve patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GONORRHEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine stop Antibiotic-Resistant gonorrhea?
- Pocket-sized HIV test could bring same-day diagnosis to community clinics
- Can a common antibiotic prevent STIs? new study tests two dosing strategies
- Meningitis b vaccine booster shows promise in kids
- Love and safety: new study tests if relationship skills can cut HIV risk
- New study offers free STI care to black youth in the deep south